Petros Pharmaceuticals, Inc. (PTPI)
OTCMKTS
· Delayed Price · Currency is USD
0.0349
+0.0001 (0.40%)
At close: Jul 3, 2025
Petros Pharmaceuticals Market Cap
Petros Pharmaceuticals has a market cap or net worth of $1.48 million as of July 3, 2025. Its market cap has decreased by -49.70% in one year.
Market Cap
1.48M
Enterprise Value
-7.45M
Revenue
5.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since December 2, 2020, Petros Pharmaceuticals's market cap has decreased from 38.73M to 1.48M, a decrease of -96.18%. That is a compound annual growth rate of -50.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 1.48M | -62.51% |
| Dec 31, 2024 | 3.94M | 27.11% |
| Dec 29, 2023 | 3.10M | -35.68% |
| Dec 30, 2022 | 4.82M | -92.98% |
| Dec 31, 2021 | 68.71M | 60.87% |
| Dec 31, 2020 | 42.71M | 10.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.60B |
| Veradigm | 823.67M |
| Nika Pharmaceuticals | 708.22M |
| Elite Pharmaceuticals | 639.84M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 557.29M |
| American Oncology Network | 418.01M |
| Northwest Biotherapeutics | 366.72M |